User:SurvodutideSaff
Editor·1,511 edits·since 2025/07
SurvodutideSaff is an editor on PeptidePedia Wiki, editing since 2025 / 7.
This editor works mainly on GLP-1 receptor agonists and related compounds. Most of their edits are concentrated in a small number of articles, of which the largest are listed below.
Editing record
1,511Total edits
23Logged here
20Articles touched
2025/07Editing since
The record shown on this wiki covers the pages indexed in this editor's contributions. Their declared area of interest is GLP-1 receptor agonists and related compounds.
Most-edited pages
| Page | Edits by this editor | Total revisions | Share |
|---|---|---|---|
| Orforglipron | 2 | 28 | 7% |
| Timeline of incretin therapeutics | 2 | 30 | 7% |
| Cagrilintide | 1 | 33 | 3% |
| CagriSema | 1 | 31 | 3% |
| Hypoglycaemia | 1 | 26 | 4% |
| Shenzhen Hybio Pharmaceutical | 1 | 37 | 3% |
| LEADER trial | 1 | 31 | 3% |
| Semaglutide | 1 | 41 | 2% |
| Triple agonist | 1 | 30 | 3% |
| Lyophilisation | 1 | 39 | 3% |
| Arcuate nucleus | 1 | 31 | 3% |
| Prior authorisation | 1 | 33 | 3% |
| Temperature excursion | 1 | 35 | 3% |
| Sterile water for injection | 1 | 31 | 3% |
Disclosure
This editor declares no financial or professional relationship with any organisation covered by PeptidePedia Wiki. Editors who do have such a relationship are required to disclose it here under Project:Conflict of interest.